PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1391990
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1391990
The global legionella testing market size was valued at US$ 312.6 Mn in 2023 and is expected to reach US$ 553.3 Mn by 2030, grow at a compound annual growth rate (CAGR) of 8.5% from 2023 to 2030.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2022 | Market Size in 2023: | US$ 312.6 Mn |
Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
Forecast Period 2023 to 2030 CAGR: | 8.50% | 2030 Value Projection: | US$ 553.3 Mn |
The global Legionella testing market is a rapidly evolving sector within the healthcare industry, primarily driven by the increasing incidence of Legionella-related diseases and the growing awareness about their prevention and control. Legionella is a type of bacterium found naturally in freshwater environments, like lakes and streams. However, it can become a health concern when it grows and spreads in human-made water systems such as showers, hot tubs, and cooling towers. Legionella testing is crucial in diagnosing Legionnaires' disease, a severe form of pneumonia caused by inhaling aerosolized water containing Legionella bacteria. The disease can be fatal, especially in individuals with compromised immune systems, making timely and accurate testing critical. The testing methods include culture methods, urinary antigen tests, and molecular methods like polymerase chain reaction (PCR).The global Legionella testing market is witnessing significant growth due to factors such as the rising prevalence of Legionnaires' disease, advancements in diagnostic technologies, and stringent regulations for preventing and controlling Legionella outbreaks. The market is also propelled by the increasing demand for rapid, accurate, and easy-to-use testing methods. Furthermore, the market's growth is bolstered by the rising awareness about the importance of maintaining water hygiene in public and private facilities, and the need for regular testing to ensure the safety of water systems. However, the high cost of advanced Legionella testing methods and lack of awareness in some regions may hinder the market growth. In conclusion, the global Legionella testing market plays a vital role in public health, offering solutions for the detection and prevention of Legionella-related diseases. With continuous advancements in diagnostic technologies and growing awareness about waterborne diseases, the market is expected to witness substantial growth in the coming years.
The market is expanding significantly as a result of factors such as the increased prevalence of illnesses linked to legionella and pneumonia, as well as the growing need for quick, sophisticated diagnostic methods and developments in bacterial testing technology. A comparatively rare cause of community-acquired pneumonia is legionella pneumonia. For instance, according to a study titled "Community-Acquired Pneumonia" that was published in August 2021, the estimated global incidence of community-acquired pneumonia ranges from 1.5 to 14 cases per 1000 person per year, with geography, season, and population factors all having a part. With 24.8 cases per 10,000 individuals in the United States annually, incidence rates increase with age.
However, complex regulations, limited expertise, and interpretation of results are expected to hamper growth of the global legionella testing market over the forecast period.